[{"NetIncomeLoss_3_Q3_USD":5649000000.0,"LiabilitiesFairValueDisclosure_0_Q3_USD":627000000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q3_USD":4200000000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-4017000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-903000000.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":54000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":895000000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":8701000000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q3_USD":170000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"RepaymentsOfLongTermDebt_3_Q3_USD":5000000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":2500000000.0,"CommonStockDividendsPerShareDeclared_1_Q3_USD":1.6,"Cash_0_Q3_USD":771000000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_3_Q3_USD":4000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":9087000000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-41000000.0,"OtherAssetsNoncurrent_0_Q3_USD":5232000000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":14000000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":0.0,"CostOfGoodsAndServicesSold_1_Q3_USD":1561000000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":4562000000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":8914000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_1_Q3_USD":-128000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_3_Q3_USD":-305000000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":1346000000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":3957000000.0,"StockRepurchasedDuringPeriodShares_3_Q3_shares":9900000.0,"StockRepurchasedDuringPeriodShares_1_Q3_shares":3000000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-270000000.0,"LongTermDebtCurrent_0_Q3_USD":91000000.0,"LongTermDebt_0_Q3_USD":34287000000.0,"AssetsCurrent_0_Q3_USD":22661000000.0,"DividendsCommonStockCash_1_Q3_USD":952000000.0,"PaymentsForProceedsFromOtherInvestingActivities_3_Q3_USD":34000000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":-29000000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":708000000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":2100000000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-202000000.0,"AccountsReceivableNetCurrent_0_Q3_USD":4094000000.0,"NotesPayableFairValueDisclosure_0_Q3_USD":40100000000.0,"AssetsFairValueDisclosure_0_Q3_USD":12309000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":589000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":592000000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q3_USD":60000000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_3_Q3_USD":65000000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":1000000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-20000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":2600000000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":2338000000.0,"EarningsPerShareBasic_1_Q3_USD":3.45,"EarningsPerShareBasic_3_Q3_USD":9.61,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":14755000000.0,"OtherLongTermDebt_0_Q3_USD":5000000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":607000000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":185000000.0,"Revenues_1_Q3_USD":6423000000.0,"Revenues_3_Q3_USD":18790000000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":1901000000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":5274000000.0,"IncreaseDecreaseInInventories_3_Q3_USD":316000000.0,"OtherAssetsCurrent_0_Q3_USD":2265000000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q3_USD":1196000000.0,"CostsAndExpenses_1_Q3_USD":3970000000.0,"CostsAndExpenses_3_Q3_USD":11659000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":5000000.0,"DerivativeFairValueOfDerivativeLiability_0_Q3_USD":573000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":1062000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":2978000000.0,"LiabilityForUncertainTaxPositionsNoncurrent_0_Q3_USD":7560000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.084,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.097,"DepreciationDepletionAndAmortization_3_Q3_USD":2728000000.0,"HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_0_Q3_USD":643000000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-1277000000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_0_Q3_USD":0.0,"CommonStocksIncludingAdditionalPaidInCapital_0_Q3_USD":31713000000.0,"EquitySecuritiesFvNi_0_Q3_USD":376000000.0,"NonoperatingIncomeExpense_1_Q3_USD":55000000.0,"NonoperatingIncomeExpense_3_Q3_USD":69000000.0,"AccountsPayableCurrent_0_Q3_USD":1161000000.0,"LiabilitiesCurrent_0_Q3_USD":9953000000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":11536000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":585000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":588000000.0,"CommonStockDividendsPerShareCashPaid_0_Q3_USD":1.6,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":2597000000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":496000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":8344000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":109000000.0,"Goodwill_0_Q3_USD":14674000000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":2000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-120000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":9087000000.0,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_3_Q3_USD":170000000.0,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1_Q3_USD":65000000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":-339000000.0,"NetIncomeLoss_1_Q3_USD":2021000000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":4816000000.0,"DebtSecuritiesAvailableForSaleRealizedGain_3_Q3_USD":37000000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-87000000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":210000000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":17224000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-375000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q3_shares":4000000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-64000000.0,"DerivativeFairValueOfDerivativeAsset_0_Q3_USD":344000000.0,"PaymentsOfDividendsCommonStock_3_Q3_USD":2823000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":17254000000.0,"InterestExpenseDebt_1_Q3_USD":302000000.0,"InterestExpenseDebt_3_Q3_USD":944000000.0,"LongTermDebtNoncurrent_0_Q3_USD":34196000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_Q3_shares":4000000.0,"OtherGeneralExpense_1_Q3_USD":1000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":8800000000.0,"PaymentsToAcquireEquityMethodInvestments_3_Q3_USD":3154000000.0,"InventoryNet_0_Q3_USD":3942000000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":-301000000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":3273000000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":2281000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":2206000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":6256000000.0,"OperatingIncomeLoss_1_Q3_USD":2453000000.0,"OperatingIncomeLoss_3_Q3_USD":7131000000.0,"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_1_Q3_USD":-11000000.0,"CommonStockSharesAuthorized_0_Q3_shares":2750000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-120000000.0,"Assets_0_Q3_USD":64637000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":11589000000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":2551000000.0,"StockRepurchasedDuringPeriodValue_3_Q3_USD":2276000000.0,"StockRepurchasedDuringPeriodValue_1_Q3_USD":752000000.0,"StockRepurchasedAndRetiredDuringPeriodValue_1_Q3_USD":752000000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":31979000000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":5329000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":2400000000.0,"EarningsPerShareDiluted_1_Q3_USD":3.43,"EarningsPerShareDiluted_3_Q3_USD":9.54,"CommonStockSharesOutstanding_0_Q3_shares":583500000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":31000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":3050000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":2400000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-19851000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q3_USD":2200000000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":11587000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":435000000.0,"StockholdersEquity_0_Q3_USD":10959000000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1759000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":700000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":64637000000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":712000000.0,"OtherGeneralExpense_3_Q3_USD":162000000.0,"Ticker":"AMGN","CIK":"318154","name":"AMGEN INC","OfficialName":"Amgen Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"135245056296.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20201029"}]